Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis 英文参考文献.docVIP

Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis 英文参考文献.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis 英文参考文献

SolubleBeta-AmyloidPrecursorProteinIsRelatedto DiseaseProgressioninAmyotrophicLateralSclerosis PetraSteinacker1,LubinFang1,JensKuhle2,AxelPetzold3,HayrettinTumani1,AlbertC.Ludolph1, MarkusOtto1,JohannesBrettschneider1* 1DepartmentofNeurology,UniversityofUlm,Ulm,Germany,2DepartmentofNeurology,UniversityofBasel,Basel,Switzerland,3DepartmentofNeuroimmunology, UCLInstituteofNeurology/NationalHospitalforNeurologyandNeurosurgery,QueenSquare,London,UnitedKingdom Abstract Background: Biomarkers of disease progression in amyotrophic lateral sclerosis (ALS) could support the identification of beneficialdrugsinclinicaltrials.Weaimedtotestwhethersolublefragmentsofbeta-amyloidprecursorprotein(sAPPaand sAPP?)correlatedwithclinicalsubtypesofALSandwereofprognosticvalue. Methodology/PrincipalFindings:Inacross-sectionalstudyincludingpatientswithALS(N=68)withclinicalfollow-updata over6months,Parkinson’sdisease(PD,N=20),andage-matchedcontrols(N=40),cerebrospinalfluid(CSF)levelsofsAPPa a, sAPP? and neurofilaments (NfHSMI35) were measured by multiplex assay, Progranulin by ELISA. CSF sAPPa and sAPP? levelswerelowerinALSwitharapidly-progressivediseasecourse(p=0.03,andp=0.02)andwithlongerdiseaseduration (p=0.01 and p=0.01, respectively). CSF NfHSMI35 was elevated in ALS compared to PD and controls, with highest concentrationsfoundinpatientswithrapiddiseaseprogression(p,0.01).HighCSFNfHSMI3 waslinkedtolowCSFsAPPa andsAPP?(p=0.001,andp=0.007,respectively).TheratiosCSFNfHSMI35/CSFsAPPa,-?wereelevatedinpatientswithfast progressionofdisease(p=0.002each).CSFProgranulindecreasedwithongoingdisease(p=0.04). Conclusions: This study provides new CSF candidate markers associated with progression of disease in ALS. The data suggestthatadeficiencyofcellularneuroprotectivemechanisms(decreaseofsAPP)islinkedtoprogressiveneuro-axonal damage(increaseofNfHSMI35)andtoprogressionofdisease. Citation:SteinackerP,FangL,KuhleJ,PetzoldA,TumaniH,etal.(2011)SolubleBeta-AmyloidPrecursorProteinIsRelatedtoDisease

您可能关注的文档

文档评论(0)

1234554321 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档